Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.80
BATS BZX Real-Time Price
As of 3:14pm ET
 0.00 / 0.00%
Today’s Change
0.97
Today|||52-Week Range
2.02
-4.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues2.3M2.2M2.1M2.9M
 
 
 
 
 
Cost of Goods Sold682.5K175.1K299.2K183.4K
 
 
 
 
 
Depreciation And Amortization125.3K139.5K149.8K149.3K
 
 
 
 
 
 
Operating ExpensesGross Income1.4M1.9M1.7M2.5M
 
 
 
 
 
General Expenses6.7M6.4M8.1M6.4M
 
 
 
 
 
Research And Development4.2M2.3M4.0M2.3M
 
 
 
 
 
Total Operating Expenses7.5M6.7M8.5M6.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.3M-4.5M-6.4M-3.9M
 
 
 
 
 
Extraordinary Credit0.000.001.7M100.0K
 
 
 
Extraordinary Charge-472.7K-1.3M-1.4M-4.3M
 
 
 
 
 
Pre-Tax Equity Earnings-262.2K-261.6K-262.2K-6.2K
 
 
 
 
 
Interest Expense On Debt920.9K927.4K966.6K1.6M
 
 
 
 
 
Other Expenses53.5K32.7K26.5K-4.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.9M-6.9M-7.3M-9.7M
 
 
 
 
 
Minority Interest0.000.00-100.00-241.00
 
 
 
Preferred Dividend0.00---46.0K0.00
 
 
Net Income-6.9M-6.9M-7.3M-9.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS150.2M149.9M149.8M150.1M
 
 
 
 
 
Shares To Calculate EPS Diluted150.2M149.9M149.8M150.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.05-$0.05-$0.06
 
 
 
 
 
EPS Diluted-$0.05-$0.05-$0.05-$0.06